|
ESYT2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.030400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.547900E-02 |
| Normal-vs-Stage2 |
7.959800E-01 |
| Normal-vs-Stage3 |
6.068200E-01 |
| Normal-vs-Stage4 |
4.525600E-01 |
| Stage1-vs-Stage2 |
2.346000E-01 |
| Stage1-vs-Stage3 |
9.702200E-03 |
| Stage1-vs-Stage4 |
9.860300E-03 |
| Stage2-vs-Stage3 |
5.031400E-01 |
| Stage2-vs-Stage4 |
3.824400E-01 |
| Stage3-vs-Stage4 |
7.852600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.673200E-01 |
| Normal-vs-AfricanAmerican |
3.365400E-01 |
| Normal-vs-Asian |
8.992400E-02 |
| Caucasian-vs-AfricanAmerican |
9.264000E-02 |
| Caucasian-vs-Asian |
8.281700E-03 |
| AfricanAmerican-vs-Asian |
2.756900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.069800E-01 |
| Normal-vs-Female |
5.039000E-01 |
| Male-vs-Female |
9.090400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.180000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.797400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.630800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.532000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.567200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.878400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.144200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.405400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.474200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.134400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.078400E-02 |
| Normal-vs-Grade 2 |
2.941700E-02 |
| Normal-vs-Grade 3 |
9.107200E-01 |
| Normal-vs-Grade 4 |
7.538200E-02 |
| Grade 1-vs-Grade 2 |
5.552600E-01 |
| Grade 1-vs-Grade 3 |
1.475220E-01 |
| Grade 1-vs-Grade 4 |
1.936440E-02 |
| Grade 2-vs-Grade 3 |
1.468390E-02 |
| Grade 2-vs-Grade 4 |
1.587420E-04 |
| Grade 3-vs-Grade 4 |
4.241700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.464500E-03 |
| Normal-vs-ccB subtype |
9.129800E-01 |
| ccA subtype-vs-ccB subtype |
5.395500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.446400E-01 |
| Normal-vs-N1 |
8.087400E-01 |
| N0-vs-N1 |
9.631800E-01 |
|
|
